Uncategorized

$RWBYF 420 with CNW – New Poll Finds Majority of Americans Support Drug Decriminalization

A recent poll conducted by the Drug Policy Alliance (“DPA”) and the American Civil Liberties Union (“ACLU”) has found that more than half of the voters in America are in favor of the drug war coming to an end and also support the decriminalization of the simple possession of substances which are presently illegal.

The poll was conducted last month and interviewed 800 registered voters. Its results were released just before the 50th anniversary of the declaration of the drug war by former president Richard Nixon, which began a system of mass criminalization, which disproportionately targeted individuals of color. Of those surveyed, more than 60% were found to support the elimination of criminal penalties for drug possession and reinvesting resources used for drug enforcement into addiction and treatment services. Another 65% agreed that the United States should withdraw from the drug war.

Surprisingly, the survey also found that a considerably large number of voters felt that the war on drugs had failed. By party affiliation, 82% of members of the GOP, 85% of independents and 83% of Democrats regarded the war on drugs as a failure.

In a press release, the ACLU Justice Division’s director Udi Ofer stated that President Joe Biden should move to dismantle the system of mass incarceration and overpolicing as per his campaign promises, on the anniversary of the war on drugs. In addition to this, the poll also found that more than 60% of those surveyed believed that the use of drugs shouldn’t be treated as a criminal justice issue and should instead be viewed as a public health issue, while another 61% supported the commuting of sentences for drug-related convictions. An additional 64% supported the revocation of mandatory minimum sentences in cases related to drugs.

Ofer asserted that the time had come to embrace new approaches that treated substance use as a public health issue. He noted that the Biden administration could make progress in ending this racist and harmful war by reducing the sentences of individuals imprisoned for drugs. This, he said, would help decrease the over policing of Brown and Black communities in the United States, as well as decrease the problem of mass incarceration.

President Biden has vocalized his support for ending imprisonment for low-level drug cases, stating that no individual should be incarcerated for using drugs. He added that the country should change the way they dealt with drug abuse. However, the Biden administration has yet to take any steps to alter federal policy. Additionally, the president hasn’t granted presidential clemency to individuals imprisoned for drugs.

Should federal marijuana policy ever be relaxed, industry players such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) will have fewer regulatory headaches to contend with as a degree of uniformity may be brought to the currently fractured industry.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Thursday, June 17th, 2021 Uncategorized Comments Off on $RWBYF 420 with CNW – New Poll Finds Majority of Americans Support Drug Decriminalization

$NEXCF AR/VR and AI Tech in Education Creating Unique Opportunities for Early Investors

NetworkNewsWire Editorial Coverage: How and what students learn is always changing, but the landscape has become particularly frantic lately with ubiquitous digital technologies. Digital technologies have changed nearly everything, including the student-school-teacher paradigm from kindergarten to higher education to how and who companies hire. The COVID-19 pandemic, a growing choir of voices calling for educational equality, outlandish tuition costs and even so-called “wokeness” have people and companies rethinking educational dynamics. In the thick of it is the burgeoning educational technology (edtech) industry, which is growing rapidly to meet evolving demand from today’s generation of digitally native learners, as evidenced by both analyst forecast and upstarts such as Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (Profile) immediately finding customers for its new digital learning platform. The evolution also spotlights other companies in the space, including Chegg Inc. (NYSE: CHGG)Grand Canyon Education Inc. (NASDAQ: LOPE)Stride Inc. (NYSE: LRN) and Strategic Education Inc. (NASDAQ: STRA) for what they bring to the table to help people of all ages learn and excel.

  • Growing at a 19.9% CAGR through 2028, the global edtech market is forecast to reach $380 billion.
  • Nextech AR Solutions has parlayed its retail technology into its exclusive EdTechX platform.
  • EdTechX has been labeled co-sell ready by Microsoft, a designation that should expedite sales.
  • Ryerson, Nextech were awarded up to $150,000 for the creation, delivery of AR learning experiences.

Edtech: A $380 Billion Industry

The value of compounding interest comes in handy when considering that analysts at Grand View Research estimate that the global education technology market grew from $86 in 2020 billion to $106 billion in 2021. Grand View forecasts a stunning 19.9% compound annual growth through 2028, implying the market size will surge to $379.8 billion in that time. Fueling the growth is the fact that the movement is global, including emerging markets in Africa where tech is providing wider access to learning.

Looking ahead, the future of education involves considering technology here and on the horizon, including things such as virtual reality (“VR”), augmented reality (“AR”) and machine learning (“ML”). AR has already become incredibly useful and popular today, overlaying real word visuals with computer-generated objects in real time. The utility is amazing, as learning becomes interactive and engaging without the user having to be immersed in a computer-generated world. Grand View sees the global AR market growing also exploding; it forecasts a 43.8% compound annual growth rate to $340.2 billion by 2028.

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) specializes in developing and operating AR platforms, three-dimensional product visualizations, human holograms and 360° portals. The company was voted a 2019 Top-20 Most Promising AR/VR Tech Solutions by CIO Review, and NTAR calls many Fortune 500 companies clients for an array of applications, such as e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences.

All told, the company has curated more than 4,100 events for clients that hosted in excess of 10 million visitors. That proven technology undergirded the company’s R&D of a new product to disrupt the higher education market. That’s exactly what seems to be happening with the recent launch of EdTechX, a comprehensive education product combining enterprise-scale video streaming, integrated assessments, AR holograms and data analytics.

Augmented and Remote Learning Just Tip of Iceberg

With its flagship business model, Nextech has already made inroads in the higher education markets. Ryerson University, Carnegie Mellon University, University of South Florida, Université Laval (in Quebec City, Quebec) and UN Educational, Scientific and Cultural Organization (“UNESCO”) are just a few of the clients already in the company’s portfolio. Of course, they would be natural fits for EdTechX as well, and some have already made the leap, including Ryerson, Carnegie Mellon and Black Student Fund.

The opportunities are only limited to the imagination. Nextech can provide virtual learning labs, digital courses and poster sessions, live demos and collaborations, Q&A sessions, teaching tools, downloadable course content and more. Applications aren’t limited to the classroom either, with homecoming events, convocations and career fairs all available for design.

As demonstrated in this video, Ryerson and Nextech collaborated to incorporate AR and hologram technologies to develop customized virtual labs for different Ryerson science programs. On June 10, Ryerson and Nextech were jointly awarded from eCampusOntario, a provincial-run program, up to $150,000 for the creation and delivery of AR learning experiences for use within post-secondary education institutions.

Don’t Overlook the Microsoft Effect

With the new EdTechX platform being commercialization, Nextech this month launched its LiveX platform on Microsoft Azure. This presents an opportunity for EdTechX to be seen by the more than 5,300 colleges and universities in the United States and give those educational institutions the change to transform traditional learning and events into digital experiences for the more than 19 million students they enroll.

Only days after the launch, EdTechX was deemed by Microsoft to be co-sell ready, an accomplishment with tremendous implications. Co-seller is the upper echelon of Microsoft partners and is reserved only for elite global independent software vendors (“ISVs”), a branding that speaks volumes to the quality of the technology and platform for potential customers. The Microsoft co-seller process includes building demand, sales planning, sharing sales leads, accelerating partner-to-partner empowered selling and delivering marketplace-led commerce.

“Nextech AR Solutions is helping education institutions digitally transform the way educators teach and the way students learn, by enabling remote experiential learning through EdTechX. Studies have shown that these types of immersive technologies improve student engagement and student outcomes,” commented Nancy Teodoro, education partner lead at Microsoft Canada, on the new agreement.

Attracting Clients, CEO Support

It doesn’t take a Rhodes Scholar to recognize the revenue opportunities involving the exploding edtech and AR markets mentioned above. As it happens, though, Nextech is staring at some of the best up-and-coming markets in general when it comes to attracting clients.

Each year, the U.S. Labor Department releases its forecast for expansion and contraction in specific industries. Look at those estimates released in September shows that Nextech AR and digital experience platform services customers represent eight out of the top 10 for fastest-growing industries.

Genuine passion for management is always encouraging for stakeholders to see, but it pales in comparison to a CEO repeatedly laying out money to keep building a position. Nextech CEO Evan Gappelberg wears his optimism about the future of the company on his sleeve for the world to see.

In May, Gappelberg made his seventh purchase of Nextech stock in the last year-and-a-half. This time he exercised warrants for $186,650 worth of stock, putting money in the company’s coffers while increasing his overall holdings to 9.86 million shares. Gappelberg explained his outlook on the company in depth during a recent Nextech presentation at the 2021 LD Micro Invitational.

Getting in Front of the New Way to College

How big is a big enough market opportunity? $100 billion? $500 billion? Fact is that while size is important, it is timing the penetration of the market that generally determines if a company can capture any share. Edtech, AR and other digital learning technologies still have a lot of runway to grow long legs in the coming years. Traditional universities are going to have to learn to adapt, while others are already charting a good course.

Chegg Inc. (NYSE: CHGG), a digital textbook rental service and loose version of an online tutor, is wildly popular among high school and college students the world over. The company’s newest offering, launched this month, is branded Uversity, a platform that facilitates educators and faculty members share things such as notes, videos and practice tests with Chegg members, albeit students or educators.

Grand Canyon Education Inc. (NASDAQ: LOPE) (“GCE”) provides a spate of education services to 26 colleges and universities in the United States, including learning management systems, internal administrations, academic services, counseling services and more. GCE has developed significant technological solutions, infrastructure and operational processes to provide superior services that support the students, faculty and staff of its partner institutions.

Stride Inc. (NYSE: LRN) is a technology-based education company that provides proprietary and third-party online curriculum, software systems, and educational services to facilitate individualized learning for students primarily in kindergarten through 12th grade (K-12) in the United States and internationally. A key opinion leader as well, a recent survey conducted by Stride with third-party research provider Qualtrics determined that most parents want more choices and experience for their kids when it comes to education, especially established virtual learning platforms.

Strategic Education Inc. (NASDAQ: STRA) is an education services holding company best known for its for-profit online schools Capella University and Strayer University, as well as non-degree programs schools such as DevMountain, Hackbright Academy, and Sophia Learning. Capella is expanding its degrees while keeping the workload flexible for its students. More than 10,000 students are now part of the FlexPath program, which allows students to move at their own pace but incentivizes them to go quickly through a pay schedule based on time rather than credit hours.

Where education is going next will likely remain fluid, but the standard of most students attending a four-year, on-campus university looks to be shifting. Technology has changed that forever with the potential to earn the same degree via different channels. Companies that are getting in front of the new paradigm, especially those leaning on technology, should prosper going forward.

For more information about Nextech AR Solutions, please visit Nextech AR Solutions.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Thursday, June 17th, 2021 Uncategorized Comments Off on $NEXCF AR/VR and AI Tech in Education Creating Unique Opportunities for Early Investors

$EXN Set To Benefit from a Sustained Silver Demand Boom from the Electric Vehicle Sector

  • Battery-powered electric vehicles are set to be a significant demand driver for silver in coming years
  • The expected increase in annual silver demand from the electric vehicle sector over the next four years is estimated to equal 10% of 2021’s global silver production
  • Excellon Resources is currently executing ongoing precious metals projects in Mexico, Idaho and Germany
  • The company recently revealed that its Mexican operations resulted in a 37% YoY increase in silver production as of the fourth quarter of 2020

Fifty grams is slightly more than the weight of an average golf ball, yet it also represents the estimated silver content contained within a battery electric vehicle (“BEV”) (https://ibn.fm/IzGx9). Silver has historically enjoyed widespread usage within the automotive sector, a reflection of its superior electrical conductivity properties, excellent oxide resistance and durability under harsh operating environments. With electric vehicles rapidly rising as a proportion of global automotive sales, the sector is transforming into a powerful demand center for silver, with The Silver Institute forecasting that the automotive industry will absorb nearly 90 million ounces of silver annually by 2025, a significant increase from this year’s anticipated demand of 61 million ounces (1,900t). To put that figure into context, the expected annual demand from the electric vehicle sector is expected to increase over the next four years to over 10 percent of annual global silver production, based on 2021 projections (https://ibn.fm/ZuQCf). The surge in demand should be particularly advantageous for companies such as Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2), a silver and base metals producer with precious metal projects in Mexico, Idaho and Germany.

Silver’s unique properties make it difficult to replace across a wide and growing array of automotive applications; furthermore, and unlike platinum group metals, the use of silver is not concentrated within a single automotive component like a catalytic converter. Rather, silver components can be found across a myriad of vehicular applications, including reversing cameras, automotive lenses, and fuel management systems, making the precious metal relatively harder to substitute. A recent study carried out by The Silver Institute has estimated the average internal combustion engine (“ICE”) vehicle to consume 15-28 grams (0.5-0.9 ounces) of silver, a figure which would increase to 18-34 grams for hybrid vehicles and to 25-50 grams for the average BEV. Notably, that figure does not take into account ancillary services which also require the use of silver, such as the construction of charging stations and charging points for electric vehicles.

While silver’s longer-term demand outlook looks bright, driven by surging demand from electric vehicle manufacturers as well as from the solar/photovoltaic industry where silver is a key component utilized in the manufacture of solar cells, sustained growth in silver mine production will necessitate further investment to bring earlier stage projects into production, thereby offsetting losses from reserve depletion and grade decline.

Excellon Resources is currently working towards developing a precious metals growth pipeline across a myriad of geographies, including: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho boasting strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany. Excellon has seen particularly promising results from its Platosa Mine located in Durango, Mexico. Over the course of 2020, the company revealed that its Mexican-based mining operations had resulted in a 37 percent year-over-year increase in silver production, with lead output rising by 32 percent and zine production growing by 19 percent (https://ibn.fm/kQwN4).

Excellon has also updated the market in April 2021 of the results of further underground expansion and exploration drilling at the Platosa Mine, which resulted in the discovery of additional high-grade silver deposits. As per the company’s announcement, further definition and expansion of the Guadalupe North, 623, NE-1 and NE-1S mantos, with results from underground drilling including:

  • 1,293 g/t silver equivalent (“AgEq”) over 6.5 metres (618 g/t Ag, 10.1% Pb and 12.0% Zn) in EX21UG565;
  • 1,571 g/t AgEq over 4.6 metres (688 g/t Ag, 14.5% Pb and 14.9% Zn) in EX21UG564; and
  • 1,031 g/t AgEq over 4.6 metres (359 g/t Ag, 4.9% Pb and 15.9% Zn) in EX20UG522A, including 1,531 g/t AgEq over 1.3 metres (573 g/t Ag, 8.6% Pb and 21.5% Zn).

With rising environmental awareness and a growing transition away from fossil fuels set to drive further growth of both the electric vehicle and photovoltaic sectors, silver demand and price momentum are expected to continue their ongoing rise in the coming future. Through its various projects and ongoing production momentum, Excellon Resources looks well positioned to capitalize on the precious metal’s renaissance.

For more information, visit the company’s website at www.ExcellonResources.com.

NOTE TO INVESTORS: The latest news and updates relating to EXN are available in the company’s newsroom at https://ibn.fm/EXN

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, June 17th, 2021 Uncategorized Comments Off on $EXN Set To Benefit from a Sustained Silver Demand Boom from the Electric Vehicle Sector

$CLXPF Announces First-Ever Trial to Treat COVID-19 Frontline Clinicians, Unveils EMBARK Model

  • The study will examine treating symptoms of depression, anxiety, burnout and post-traumatic stress
  • EMBARK is groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine
  • Cybin considers it an honor, duty to support healing processes of doctors, nurses and healthcare professionals, says CEO

In the first-ever study of its kind, Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that it is co-sponsoring a study focused on treating frontline clinicians experiencing COVID-related distress (https://ibn.fm/NvMAo). In addition to co-sponsoring the study, Cybin also announced the development of EMBARK, a groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine.

“Our nation’s doctors, nurses and clinicians have been shouldering the burden of COVID-19 by taking care of the sickest among us,” said Dr. Alex Belser, Cybin’s chief clinical officer. “They’re experiencing high levels of anxiety, depression and burnout. Now it’s our turn to help them. We are sponsoring research to see if psychedelic medicine, when used with EMBARK’s supportive therapy, can help clinicians recover from COVID-related distress.”

The study, which Cybin will be co-sponsoring in a strategic collaboration with the University of Washington, will be hosted in Seattle, one of the cities hit hardest at the outset of the pandemic, and will be led by Dr. Anthony Back, a recognized leader in the fields of palliative care and oncology. The randomized, placebo-controlled trial of psychedelic-assisted psychotherapy with psilocybin will examine treating symptoms of depression, anxiety, burnout and post-traumatic stress among frontline doctors, nurses and healthcare professionals.

“There is tremendous potential in a collaboration between the University of Washington and Cybin to move the field forward, and this project is an incredibly valuable initial step towards a productive future,” said Back, who will serve as primary investigator to the clinical trial.

Designed to support the initiative, Cybin’s EMBARK model was developed by Belser and PhD candidate Bill Brennan. Cybin noted that the development of EMBARK has been guided by leading process evidence for the clinical efficacy of psychedelic-assisted psychotherapy and demonstrated theories of therapeutic action to support healing. “EMBARK was designed as a transdiagnostic psychotherapy model that can be adapted to address a range of clinical indications and populations,” the company stated.

“For more than a year now, frontline clinicians and healthcare professionals have made immeasurable sacrifices to protect public health in their communities,” said Cybin CEO Doug Drysdale. “We consider it an honor and our duty to now help support their own healing processes, post-COVID-19. We are also delighted and proud to launch EMBARK, a ground-breaking psychotherapy model aimed at delivering best-practice, supportive healing in conjunction with psychedelic therapeutics. We look forward to working with and supporting Dr. Anthony Back on this important program.”

Cybin Corp., a leading biotech company focused on progressing psychedelic therapeutics, is on a mission to revolutionize mental health care. The company is focused on progressing psychedelic therapeutics by utilizing proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Thursday, June 17th, 2021 Uncategorized Comments Off on $CLXPF Announces First-Ever Trial to Treat COVID-19 Frontline Clinicians, Unveils EMBARK Model

$CNSP Set for Inclusion in Russell 2000 Index

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the company will be added to the Russell 2000(R) Index, effective June 25, 2021, after the close of the U.S. equity markets. CNSP will be added following the annual reconstitution of the Russell stock indexes. According to the announcement, the Russell 2000 Index, which is a subset of the Russell 3000(R) Index, measures the performance of the small-cap segment of the equity market in the United States and includes an estimated 2,000 of the smallest securities based on a combination of their market cap and current index membership. Investment managers and institutional investors commonly rely on the Russell Index for index funds and as benchmarks for active investment strategies; approximately $9 trillion in assets are benchmarked against Russell’s U.S. indexes. The indexes are part of global index leader FTSE Russell, which provides innovative benchmarking, analytics and data solutions for investors worldwide. “We are pleased to meet this noteworthy milestone and be included in the Russell 2000 Index,” said CNS Pharmaceuticals CEO John Climaco in the press release. “As our team continues to drive our clinical program forward for the treatment of glioblastoma multiforme (‘GBM’), we believe this inclusion well-positions us to drive market awareness. We are honored to be listed among our industry peers on what is considered to be a widely respected performance benchmark for small-cap companies. We look forward to leveraging the access and positioning this inclusion brings to unlock additional value.”

To view the full press release, visit https://ibn.fm/PXgjL

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 17th, 2021 Uncategorized Comments Off on $CNSP Set for Inclusion in Russell 2000 Index

$BRSF Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment

  • BRSF has partnered with Ehave to conduct research connected to biochemical biomarkers concerning psychedelic drug administration
  • Psychedelic drugs show promise in treating neurological disorders, including chronic pain, depression, and PTSD, but more research is needed
  • BRSF’s E-Tattoo is poised to bring benefits of biomarkers to neurological and psychiatric research; allows monitoring of patient’s brain activity in a non-intrusive way

Brain Scientific (OTCQB: BRSF) has partnered with Ehave, Inc., a provider of digital therapeutics for the psychedelic and mental health sectors, to use data and AI algorithms to statistically correlate biomarkers for the identification of psychedelic drug administration as a treatment for neurological disorders such as chronic pain, depression (major and persistent), PTSD, bipolar disorder, general anxiety, ADHD and schizophrenia. Biomarkers are essential as they can help improve diagnostic accuracy and thus improve patient outcomes. There are currently 250 biochemical markers about a broad range of the body’s organic systems and how they function, but this approach still remains a challenge for psychiatric disorders. The partnership between Brain Scientific and Ehave is intended to change this (https://ibn.fm/eX4AD).

Mental health disorders are affecting more and more people worldwide — it has been estimated that 51.5 million adults (20.6%) experienced mental illness in 2019 in the US alone (https://ibn.fm/6C81O). Psychedelic drugs are increasingly becoming part of mainstream psychiatry conversation. A growing body of evidence indicates that they could be effective for treating a range of mental illnesses, especially when coupled with talking therapy (https://ibn.fm/BW9pa). This breakthrough could potentially have profound implications for a space that has seen few pharmacological advancements over recent decades regarding the treatment of mental disorders affecting millions of people around the world, including depression, anxiety, PTSD, addiction, and more. Still, experts caution that more research is needed.

This is where the partnership between Brain Scientific and Ehave can potentially make a difference. The two companies signed the MoU defining a collaboration framework that will allow them to exploit graph-based AI and linked data protocols to develop neural net algorithms. As an initial use case, the neural net algorithm would be used to upload an already trained neuronet into a specialized chip, a temporary E-Tattoo, developed by Brain Scientific.

Brain Scientific would also contribute to the collaboration by providing its proprietary data signal acquisition technology, NeuroCap, and NeuroEEG. These devices, designed to collect and read brain activity, would be linked to the Ehave platform. Brain Scientific will also provide the training and support needed to operate the installed equipment, the required software, and hardware and will develop and validate products within three months of receiving any specifications from Ehave.

As part of the MoU, Ehave’s role would be to acquire real-time patients data from Brain Scientific’s NeuroCap and NeuroEEG and transfer it into a cloud. Both Ehave and Brain Scientific will jointly own the data from this collaboration.

In addition, Ehave could seek to leverage its network of partner healthcare providers, including psychiatrists, psychologists, psychotherapists, and general practitioners, to use NeuroCap and NeuroEEG in clinical settings and collect the data about the electrophysiological changes in brain pre, mid and post-psychedelic drug administration.

The collaboration could lead to building or partnering with functional labs where NeuroCap and NeuroEEG devices could be deployed to conduct market studies on consumer behavior and psychology and collect data on various brain-related physiological and mental disorders. These labs are likely to start in Australia and could be rolled out in other parts of the world where Ehave has its footprint.

With E-Tattoo, an EEG device about the size of a stamp, Brain Scientific allows continuous measurement of patients’ brain activity in a non-intrusive way and with minimal distraction from everyday life. Brain Scientific believes that the future of EEG testing will be based on non-invasive measures of the brain via 3D temporary imprint or implanted graphene electrodes. Graphene, often called the wonder material of the 21st century, could potentially allow the development of smaller electrodes — even thinner than a human hair. The two companies are poised to leverage their unique expertise and work together to make a big step forward in neurological and psychiatric research by utilizing graph-based AI and linked data protocols to help develop biomarkers for psychiatric disorders.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, June 17th, 2021 Uncategorized Comments Off on $BRSF Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment

$XPHYF Looks to Focus Expertise on Psychedelic Drug Formulation as Manufacturing Programs Advance

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community. The audio press release discusses the company’s recent announcement regarding the status of its GMP mescaline synthesis program. “With both its North American GMP mescaline synthesis program and German-based psilocybin biotechnology production underway, the first stage of XPhyto’s psychedelic medicine program is progressing on schedule. As the manufacturing programs advance, we look forward to focusing our expertise on psychedelic drug formulation,” said XPhyto’s CEO and Director Hugh Rogers. “We see a significant market opportunity in the production of pharmaceutical grade psychedelics followed by the standardization of dosage formulations with precise, predictable and efficient drug delivery for clinical study and therapeutic use.”

To view the full press release, visit https://ibn.fm/UlSv8

About XPhyto Therapeutics Corp.

XPhyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets. For more information, visit the company’s website at www.Xphyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at http://ibn.fm/XPHYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $XPHYF Looks to Focus Expertise on Psychedelic Drug Formulation as Manufacturing Programs Advance

$TOBAF Poised to Enhance Competitive Position in Tobacco Industry

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2), which filed the original provisional patent with the United States Patent and Trademark Office in September 2020, is now a step closer to being a patent owner. Its patent filing has advanced to nonprovisional status, with the assignment of a patent examiner currently pending. Patents can play an important role in TAAT’s market positioning and preserve the competitive advantages of patent protection. Per TAAT CEO Setti Coscarella, who was quoted in a recent article, “The intellectual property protection afforded by a patent on the Beyond Tobacco base material of TAAT could improve our competitive position in the tobacco industry. Aside from the fact that it would be more difficult for competitors to imitate our product, it would be more practical for us to manufacture Beyond Tobacco using third-party producers instead of producing only in-house, which we currently do because the process is a trade secret.”

To view the full article, visit https://ibn.fm/O984Z

About TAAT(TM) Global Alternatives Inc.

The company has developed TAAT(TM), which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original,” “Smooth,” and “Menthol” varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “big tobacco” pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $TOBAF Poised to Enhance Competitive Position in Tobacco Industry

$SBEV Announces Anheuser Busch Distributor to Carry SALT Flavored Tequila Brand in Florida

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, is now distributing its SALT (“SALT”) Tequila throughout Florida by Bernie Little Distributors. Distribution is centered on Highland, Hardee, Polk and Okeechobee counties, which collectively have a potential of approximately one million. An Anheuser Busch distributor of brands, Bernie Little also distributes Splash’s Copa di Vino. SBEV’s SALT Tequila is a naturally flavored, 100% blanco agave tequila. The beverage offers a clean and sweet taste. SALT ingredients are grown in the Jalisco, Mexico, region, where the drink is also distilled and bottled. SALT is available in berry, citrus and salted chocolate flavors. Thought to be the first agave 80 proof flavored tequila available, SALT is a unique choice in one of the fastest-growing alcoholic beverage categories. According to the announcement, tequila consumption in the United States increased 14% annually, with flavored versions reaching 10 times that of unflavored. With the addition of Bernie Little, SBEV now has five Anheuser Busch distributors in Florida alone. “We’re excited to see SALT tequila sold into central Florida, a high-growth region, by Bernie Little, a top Anheuser Busch distributor with which we’ve developed a strong relationship based on our acquired Copa di Vino brand,” said Splash Beverage CEO Robert Nistico in the press release. “When we purchased Copa di Vino, a key asset was its network of distributors with reach into over 13,000 retail locations. As a result, we are very well positioned to offer Splash’s innovative and high visibility brands through this established network of high-performing distributors.”

To view the full press release, visit https://ibn.fm/DuiQs

About Splash Beverage Group Inc.

Splash Beverage Groupspecializes in manufacturing, distribution, sales and marketing of various beverages across multiple channels. SBEV operates in both the nonalcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique because it only develops and accelerates brands it perceives to have highly visible pre-existing brand awareness or pure category innovation. For more information about the company, please visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at http://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $SBEV Announces Anheuser Busch Distributor to Carry SALT Flavored Tequila Brand in Florida

$NEXCF Companies Jockeying for Position in $106 Billion EdTech Market; Who’s in Front?

NetworkNewsWire Editorial Coverage: Last year changed the world in unexpected ways, as people and businesses looked to keep moving forward in the face of a global coronavirus pandemic. In many instances, COVID-19 simply accelerated the inevitable, such as trends towards digitization while lockdown orders were in place. Perhaps the most significant example was in education, where students from grade school to college went 100% virtual for the first time in history. Education technology, or edtech, is a hot trend that, even as the pandemic wanes, isn’t showing any signs of slowing among today’s generation of digitally native learners, as evidenced by analyst forecast and upstarts such as Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) (Profile), which is partnering with juggernaut Microsoft Corporation (NASDAQ: MSFT) for solutions to transform higher education. As it happens, Facebook Inc. (NASDAQ: FB)Alphabet Inc. (NASDAQ: GOOGL) and Coursera Inc. (NYSE: COUR) have also dedicated considerable resources reimaging education and democratizing learning for everyone, everywhere.

  • The global edtech market is estimated at $106 billion and forecast to expand at a 19.9% CAGR through 2028.
  • Nextech AR Solutions lists numerous leading educational institutions as clients and partners.
  • The company recently launched its EdTechX platform, with customers already coming on board.
  • EdTechX quickly achieved co-sell ready status with Microsoft, a partnership reserved for proven companies with highest-quality tech.

EdTech: One-Third of a $340 Billion Market

Big money has gotten behind edtech, catalyzing double-digit growth. Market analysts at Grand View Research estimate the global education technology market at $106 billion for 2021, up from about $86 billion in 2020, and on track to grow 19.9% annually through 2028 as digital technology improves access to education. The movement is global, including emerging markets such as Africa where tech is filling holes in learning.

Remote learning is one thing, but the future of education involves the marriage of remote learning to next-generation technology, including augmented reality (“AR”). With AR, computer-generated objects are seen on a screen in real time, a technique that helps students learn in a more interactive and engaging environment. Grand View sees the global AR market growing at a spectacular 43.8% compound annual growth rate to $340.2 billion by 2028.

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) is on the cutting edge of the markets as a developer and operator of AR platforms that transports 3D product visualizations, human holograms and 360° portals. The company curates its products to a diverse array of blue-chip customers, including Budweiser, JNJ and IBM, by altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences.

Nextech solutions have been used in more than 4,100 events that have been attended by more than 10 million people. Of particular interest is the company’s newly launched augmented learning platform and hybrid and virtual events products that are prime to disrupt a higher education market ripe for innovation. The platform, branded EdTechX, is gaining immediate traction.

Bring the Lab to the Kitchen Table

Nextech has already planted its flag in the university and college markets. Ryerson University, Carnegie Mellon University, University of South Florida, Université Laval (in Quebec City, Quebec), and UN Educational, Scientific and Cultural Organization (“UNESCO”) are only a few of those that trust Nextech for their needs. EdTechX is a comprehensive education product for global customers combining enterprise-scale video streaming, integrated assessments, augmented reality holograms and data analytics.

Applications abound for Nextech where it can provide virtual learning labs, digital courses and poster sessions, live demos and collaborations, Q&A sessions, teaching tools, downloadable course content and more, including uses outside the classroom such as homecoming events, convocations and career fairs. Using its AR and hologram technologies, Nextech worked with Ryerson to develop customized virtual labs for a several different science programs of the university.

Partnered with Microsoft for Sales

Nextech’s EdTechX is a new offering; the company just launched its LiveX platform built on Microsoft Azure this month. Ryerson, Carnegie Mellon and Black Student Fund have already implemented EdTechX into their daily operations. While impressive, this is just scratching the surface, where in the United States alone there are upwards of 5,300 higher education institutes that enroll more than 19 million students.

In addition, EdTechX has achieved Microsoft’s co-sell ready status, a milestone that should not go understated. A Microsoft co-seller process includes building demand, sales planning, sharing sales leads, accelerating partner-to-partner empowered selling and delivering marketplace-led commerce. This is the top tier for Microsoft partners, and qualifying puts Nextech in an elite group of global independent software vendors (“ISVs”) that are transforming industries.

A Microsoft co-seller agreement allows Nextech to work with Microsoft sales teams to actively fulfill customer needs globally, which speaks to the quality of EdTechX and Nextech, as Microsoft reserves this type of relationship exclusively for companies with outstanding technology and a proven customer track record.

“Nextech AR Solutions is helping education institutions digitally transform the way educators teach and the way students learn, by enabling remote experiential learning through EdTechX,” said Nancy Teodoro, education partner lead at Microsoft Canada.

Clients in High-Growth Markets, CEO (Keeps) Buying

In September, the Bureau of Labor Statistics released its projections for industry growth and contraction for the next decade. As it happens, Nextech is in the catbird’s seat considering that Nextech AR and digital experience platform services customers represent eight out of the top 10 for fastest-growing industries.

Investors always love to see “skin in the game” in the form of management laying out their own cash to buy shares of stock. To that end, Nextech CEO Evan Gappelberg remains “extremely excited about our business prospects,” proving that optimism by yet again increasing his ownership position. At the end of May, Gappelberg exercised warrants for another $186,650, marking his seventh purchase in the last 18 months. In that time, the Nextech chief executive has bought 1.54 million shares, increasing his total holdings to 9.86 million shares. Gappelberg explained his outlook on the company in depth during a recent Nextech presentation at the 2021 LD Micro Invitational.

Sub5

Regardless of its $100 billion market status, the edtech market is still in its nascency. So is AR for that matter. The beauty is that they are emerging into an audience of young adults that have known nothing but the digital world, which virtually ensures mass adoption to rapidly re-shape the higher education landscape and new brand of pedagogues in the coming years.

Microsoft Corporation (NASDAQ: MSFT) has unprecedented scale and influence to play an important — and profitable — role in the global adoption of digital education. In aggregate, millions of companies and consumers (students, teachers, schools, etc.) will leverage the Azure architecture. The company is an education advocate and active in promoting online classrooms through its Microsoft Teams for Education and providing free access to a litany of its online education and learning tools.

Facebook Inc. (NASDAQ: FB) is much more than just a social media platform and ad-revenue generating behemoth. While it doesn’t take a conventional route, the company is active on many different levels in the edtech space, including its Oculus VR (virtual reality) unit that it acquired in 2014 for approximately $2 billion. Doing what it does best, Facebook uses tech to disseminate information, albeit for peer-to-peer programs for educators, policy protocols, building communities. Facebook also provides specific content to teach digital marketing to students at all levels of higher education.

Alphabet Inc. (NASDAQ: GOOGL) is the parent of Google for Education, which works with many higher education universities on different verticals in addition to offering its Google Workspace products. Many may think of just search and ads when it comes to Google, but its education unit has many successes to its name, including working with the University of South Carolina to use cloud computing to study climate change and Brown University to use VR to recreate colonial history.

Coursera Inc. (NYSE: COUR) is new to the public markets, completing its IPO on March 31 to raise $520 million by offering 15.73 million shares at $33 each. The Silicon Valley-based pure-play EdTech company offers people access to online courses and thousands of degrees from a spate of universities. Business boomed during the pandemic, with revenue climbing 59% to $293 million in 2020, although net losses grew year-over-year by $20.1 million to $66.8 million.

As it does in so many other components of life, technology has improved the value chain of education. The benefits are overarching, to say the least, and level the playing field for students of all ages in all geographic regions wishing to receive any degree that typically would have only been possible via on-campus schooling.

For more information about Nextech AR Solutions, please visit Nextech AR Solutions.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $NEXCF Companies Jockeying for Position in $106 Billion EdTech Market; Who’s in Front?

$NETE 7-Eleven to Install 500 EV Chargers by Next Year’s End

The shift towards electrification and clean energy is not limited to only automakers and electric vehicle (“EV”) makers. 7-Eleven Inc., an Irving, Texas-based convenience retailer with hundreds of stores across the United States and Canada has unveiled plans that will push the chain to the forefront of sustainability. In a move that will accelerate its environmental conservation goals by years, the convenience giant has announced that it plans to construct a minimum of 500 EV charging stations at 250 stores in the United States and Canada by the end of 2022.

The 500 DC Fast Charging (“DCFC”) ports are expected to be a major addition to the 22 already existing charging stations installed at 14 7-Eleven stores in 14 countries. Once the installation of these DCFC ports is complete, the Texas-based compay claims that it will be among the most widespread and compatible EV fast-charging networks in America, rivaling any such systems that have been installed by most retailers in the country. Aside from high upfront costs, range anxiety is one of the main deterrents against going green for most drivers, and such a network of fast-charging infrastructure would see the convenience giant attract tons of EV drivers who would like to recharge while on the road.

According to company president and CEO Joe DePinto, 7-Eleven is always striving to come up with novel ideas and develop new technologies to serve their customers better. By installing 500 fast-charging stations, the company aims to make charging much more convenient for their customers and to play a role in the widespread adoption of alternative energy vehicles. It is the right thing to do, DePinto says, and this sentiment echoes 7-Eleven’s efforts to become a leader in green energy and sustainability, especially in the retail sector.

The Texas-based retailer had previously pledged to reduce its CO2 emissions by 59% by 2030, but it managed to achieve part of this goal nearly eight years in advance of its planned schedule, reducing its carbon emissions by 20% in 2019. Additionally, 7-Eleven has stated that a minimum of 800 of its stores in Texas and in excess of 300 stores in Illinois are powered by wind energy. An additional 150 stores in Virginia run on hydroelectric power while 300 of its stores in Florida rely on solar power.

7-Eleven operates more than 79,000 convenience stores worldwide, with more than 10,000 of them in North America. So while its efforts at sustainability may seem like a drop in the ocean, this is a great start, and it is certainly more effort than any other retailer has put into reducing its carbon footprint.

As industry actors such as Net Element (NASDAQ: NETE) look to increase their EV offerings, the complementary work being done by 7-Eleven and other corporates could make EV adoption swifter than initially expected.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $NETE 7-Eleven to Install 500 EV Chargers by Next Year’s End

$UUUU Partners with Global Leader in Rare Earth Separation

  • UUUU is focused on building fully integrated, rare earth supply capabilities
  • Carester is recognized as leading authority, global consultants on rare earth supply chains
  • Energy Fuels committed to restoring critical U.S. domestic rare earth capabilities

In its ongoing commitment to developing its rare earth element (“REE”) business, Energy Fuels (NYSE American: UUUU) (TSX: EFR) is working with Carester SAS, a leading global expert on rare earth separation (https://ibn.fm/lb61d). UUUU is working with Carester to conduct a scoping study for the development of a solvent extraction REE separation circuit at Energy Fuels’ White Mesa Mill in Utah.

“Energy Fuels is absolutely focused on building fully integrated rare earth supply capabilities at our White Mesa Mill in the coming years, and we are pleased to have Carester on the team to support our efforts,” said Energy Fuels president and CEO Mark S. Chalmers, President and CEO of Energy Fuels. “Since we began evaluating the potential to produce rare earth products in late 2019, Energy Fuels has partnered with only the best global experts at every opportunity, and the agreement with Carester is just another example of how our company is advancing our strategy on the complete REE production sequence.”

Last year Energy Fuels announced its intent to explore the potential of producing separated REE oxides, REE metals, REE alloys and other value-added REE products at its White Mesa Mill with the objective of creating a fully integrated U.S. REE supply chain in the coming years. Partnering with Carester represents a key component of that development.

Energy Fuels and Carester will be evaluating the next steps as the company moves forward with its planned development of REE separation capabilities at the White Mesa Mill. Energy Fuels anticipates using existing equipment and infrastructure as much as possible as it works to create a continuous, integrated and optimized rare earth production sequence. Part of the study calls for Carester to evaluate the mill’s current monazite leaching process; the Carester team will also prepare an REE separation flow sheet, calculate capital and operating expense estimates, analyze where new technologies need to be incorporated and even recommend equipment vendors.

Energy Fuels opted to partner with France-based Carester because its team is recognized as a leading authority and global consultants on rare earth supply chains, offering invaluable insight and expertise in designing, constructing, operating and optimizing REE production facilities globally.

“Rare earth extraction, separation and purification can be complex. We believe that our extensive in-house processing experience, combined with Carester’s expertise, places the company in an excellent position to successfully and cost effectively help to restore critical domestic rare earth capabilities in the USA at the White Mesa Mill,” Chalmers said. “As more clean energy and advanced technologies are deployed, more rare earth products will be required.

However, technologies are only clean if every step in the supply chain from the mine to the final consumer product is clean,” continued Chalmers. “An electric vehicle is not green if the raw materials that go into the vehicle are not responsibly produced. The U.S. has the highest standards for safety, efficiency and environmental responsibility in the world when it comes to mining, processing, refining and manufacturing. Energy Fuels is working towards establishing a clean and green U.S. option for manufacturers who demand the highest standards in their rare earth raw materials.”

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $UUUU Partners with Global Leader in Rare Earth Separation

$CLXPF Why NIH Should Get Involved in Psychedelics Research

Investing in medicinal psychedelic research in the recent past was considered risky. Now, however, financiers and entrepreneurs are injecting money into the development of psychedelic therapies for behavioral and mental health issues. Despite this, one of the biggest public financiers of medical research in the world — the National Institutes of Health — is yet to do so.

The organization’s absence in psychedelic medicine may potentially be slowing the development of new innovative treatments as well as preventing researchers from entering the field.

Records show that various human populations have used psychedelics such as psilocybin, mescaline, MDMA, LSD, ibogaine, DMT and ayahuasca, just to name a few, for centuries. However, these substances made their way into Western medicine only recently, starting to show up in the ’50s and ’60s.

During this time, psilocybin and LSD were utilized in the enhancement of psychotherapy, before being classified as Schedule I drugs in the ’70s. This made their use illegal in both recreational and medical realms, with research on the substances being halted as well. However, a few years ago, philanthropic organizations and researchers begun conducting research on these substances once more, which led to the discovery of the various potentials that psychedelics possess.

For instance, results published earlier this year found that MDMA, which is commonly known as ecstasy, is effective in the treatment of PTSD. Many are hopeful that the U.S. Federal Drug Administration (“FDA”) may soon approve the use of MDMA-assisted psychotherapy.

These findings and many others have prompted venture capital firms to increase their investments in psychedelic biotech startups, with data showing that investments grew from $1 million in 2017 to more than $300 million in 2021. This is why it’s surprising that the National Institutes of Health (“NIH”) is yet to finance any research work in the field, despite the support for medicinal psychedelic research in the psychiatric field. The organization’s reluctance will continue to hinder psychedelic medicine progress, even with private financing materializing.

Apart from this, the institute’s lack of involvement is also limiting biopharmaceutical firms that depend on it to finance high-risk foundational research, which would enable them to center on drug development. If the NIH did decide to fund psychedelic research, it would allow the industry to develop psychedelic medicines for various conditions, including personality disorder, vegetative states and functional neurological disorder. However, pilot data is lacking.

Fortunately, the NIH seems to be changing its course, having recently awarded its first grant for medicinal psychedelic research earlier in April.

As the interest of the NIH in psychedelics grows, its work will add onto the contributions being made by publicly traded firms such as Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), which are looking to use psychedelics to revolutionize the way mental health conditions are treated.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $CLXPF Why NIH Should Get Involved in Psychedelics Research

$BRSF Tech to be Used in a Ketamine Clinical Study for Mental Health Care

  • Ehave announced it will utilize BRSF’s tech in an upcoming ketamine clinical study
  • BRSF’s tech will make it possible to correlate biomarkers for the identification of chronic pain, depression, PTSD, bipolar disorder, and more.
  • The data from this clinical trial has the potential to provide longitudinal insights that can link brain analysis and psychedelics

Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is on a mission to modernize brain diagnostics with cutting-edge tech that bridges the widening gap in access to quality care. The company’s technology will be part of a ketamine clinical study conducted by Ehave, Inc. (OTC: EHVVF) to establish the statistical correlation between ketamine treatment and patient improvement. To read Ehave’s full announcement regarding the Ketamine Clinical Trial, go to https://ibn.fm/VMu6o.

Ehave is a leading provider of digital therapeutics for the psychedelic and mental health sectors. The company’s primary goal is to improve standard care with digital therapeutics to prevent or treat brain disorders or diseases. By partnering with BRSF, they will leverage both data and AI to correlate biomarkers to identify chronic pain, depression, PTSD, bipolar disorder, general anxiety, ADHD, and schizophrenia.

The trial will begin the second half of 2021 and will need to enroll 35 patients. Ehave will be studying the effect of ketamine as a treatment for major depression while assessing the candidate therapy’s safety and tolerability.

Mental health disorders, in the wake of Covid-19, are on the rise. Depression alone affects over 264 million worldwide, and drug overdoses have risen 42% since the pandemic began.

“Ehave’s goal,” stated Alfred Farrington II, CIO of Ehave, “is to help practitioners make more informed decisions about mental health care. We believe the data from this clinical trial will provide longitudinal insights that can link brain analysis and psychedelics.”

Using BRSF’s technology, Ehave will be able to brain map the volunteer patients and show changes in the neuroplasticity of the brain areas impacted by the treatment. This study has the potential to create new forms of treatment for chronic mental health disorders.

BRSF’s neurological devices, NeuroCap(TM) and NeuroEEG(TM) are portable, clinical-grade, cost-efficient, easy-to-use, and allow for long-term monitoring. In addition to these benefits, BRSF’s technology is ideal for clinical studies because of the company’s AI-assisted diagnostic analysis that increases the efficiency, consistency and accuracy of the data collected.

Ehave is the newest to join the quickly expanding list of clinical studies that have taken advantage of BRSF’s next-generation technological solutions for the neurology market.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, June 15th, 2021 Uncategorized Comments Off on $BRSF Tech to be Used in a Ketamine Clinical Study for Mental Health Care

$SBEV Enters Agreement with Award-Winning Partner to Expand Brand Distribution

Splash Beverage Group (OTCQB: SBEV), a portfolio company of leading beverage brands, today announced its entry into a distribution agreement with Golden Beverage Company, a full-service, award-winning, Ogden, Utah-based beverage distributor servicing a diverse portfolio of beer, soda and energy drinks. According to the update, Splash’s TapouT isotonic sports drink, Copa Di Vino wine by the glass and Pulpoloco sangria from Spain, packaged in a first-of-its-kind biodegradable can, will join brands including Miller Lite, Coors, Dos Equis, Essentia and Jones Soda on retail shelves throughout the state of Utah. “We are continuously expanding the depth and breadth of our distribution, both in the U.S. and internationally,” said Robert Nistico, CEO of Splash. “Great brands are at their best when combined with great distribution and in Golden Beverage Company we’ve found an award-winning partner that distributes high-quality, high-profile beverages with superior service to its network of retailers. As a result of our effective marketing campaigns, a growing demographic of consumers are seeking out our brands and we’re happy they will find them on local retail shelves throughout Utah. We are very pleased to enter this distribution agreement and look forward to expanding our pipeline of brands distributed through Golden Beverage.”

To view the full press release, visit https://ibn.fm/qsERG

About Splash Beverage Group Inc.

Splash Beverage Group specializes in manufacturing, distribution, sales and marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it ONLY develops/accelerates brands it perceives to have highly visible preexisting brand awareness or pure category innovation. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at http://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 10th, 2021 Uncategorized Comments Off on $SBEV Enters Agreement with Award-Winning Partner to Expand Brand Distribution

$NEXCF Ryerson University Awarded Funds for Creation, Delivery of AR Learning Experiences

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, today announced that, together with partner, Ryerson University, it was jointly awarded an amount up to $150,000 for the creation and delivery of AR learning experiences for use within post-secondary education institutions. The award — received from eCampusOntario, the government of Ontario’s $50 million Virtual Learning Strategy (“VLS”) — will build upon the initial Ryerson Augmented Learning Experience (“RALE”) announced in 2020 and represents an expansion of these efforts. “With the help of the Ontario Government — who shares our vision of augmented reality, immersive learning — we are delivering on our goal to transform higher education,” said Evan Gappelberg, CEO of Nextech. “Ontario’s Virtual Learning Strategy is a significant initiative that creates partnerships with higher education institutions within the province and technology providers, while providing market adoption support for the resulting innovation. Innovation in the delivery of education solutions is critical and allows for added resiliency and student access in a post-COVID-19 world. We are grateful for the continued partnership with Ryerson and thrilled to play a part in this important government initiative for the benefit of multiple stakeholders, not least of whom are educators and students who are seeking and actively using new technologies.”

To view the full press release, visit https://ibn.fm/IZGs3

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality platforms that transport three-dimensional (“3D”) product visualizations, human holograms and 360° portals to its audiences, altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance), and learning and training experiences. Nextech focuses on developing AR solutions; however, most of the company’s revenues are derived from three ecommerce platforms, VacuumCleanerMarket.com (“VCM”), InfinitePetLife.com (“IPL”) and TruLyfeSupplements.com (“TruLyfe”), as well as VCM and product sales of residential vacuums, supplies and parts, and small home appliances sold on Amazon. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at http://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 10th, 2021 Uncategorized Comments Off on $NEXCF Ryerson University Awarded Funds for Creation, Delivery of AR Learning Experiences

$IDEX to Join Russell 3000 Index

Ideanomics (NASDAQ: IDEX) today announced that it will be joining the broad-market Russell 3000(R) Index at the conclusion of the 2021 Russell indexes annual reconstitution, which is expected to take effect after the US market opens on June 28. “Joining the Russell indexes enables Ideanomics to extend its reach into the institutional shareholder community where we believe our story is going to resonate extremely well. Our ability to derive revenues from the EV industry in the short, medium and long-term, sets us apart from many others in the sector, while our fintech group provides consistent results and spotlights our value to shareholders both today and tomorrow,” Ideanomics CEO Alf Poor stated in the news release. “We plan to utilize our inclusion in the Russell indexes as a platform to grow shareholder awareness which, with our team is executing our plans, delivering on commitments, and driving growth across our businesses, helping us stand out as a stock with breakout potential in an otherwise frothy market.”

To view the full press release, visit https://ibn.fm/kjblI

About Ideanomics Inc.

Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. The Ideanomics Mobility division is a service provider that facilitates the adoption of electric vehicles by commercial fleet operators through offering vehicle procurement, finance and leasing, and energy management solutions under an innovative sales to financing to charging (“S2F2C”) business model. Ideanomics Capital is focused on disruptive fintech solutions for the financial services industry. Together, Ideanomics Mobility and Ideanomics Capital provide global customers and partners with leading technologies and services designed to improve transparency, efficiency and accountability, and shareholders with the opportunity to participate in high-potential, growth industries. For more information, visit the company’s website at www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at http://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 10th, 2021 Uncategorized Comments Off on $IDEX to Join Russell 3000 Index

$BRSF Poised to Offer Brain Monitoring Solution as Research Shows Neurological Findings in COVID-19 Long-Haulers

  • Most extensive research to date reports significant neurological problems in patients who suffered from so-called long-haul COVID-19
  • Neurological issues range from mild to more severe such as cognitive impairment, which affects around 20% of these patients
  • BRSF appears poised to be part of the solution as long-haulers need monitoring so that doctors can assess if they have neurological disorders

The neurological and psychiatric aftermath of COVID-19 has been reported, but adequately assessing the effects of the disease on brain health still remains a challenge. A new preprint analysis, representing one of the most extensive studies of neuropsychiatric symptoms among COVID-19 long-haulers, reports that patients who have been sick with COVID-19 for more than three weeks experience cognitive impairment at least six months after the infection (https://ibn.fm/OSDQx). Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, is poised to provide brain monitoring capabilities to enable clinicians to study the brain wave activity of patients with neurological conditions.

So-called long COVID has gained momentum over the past year as some patients reported persistent neurological and psychiatric manifestations after their initial infection. The extensive research studied nearly 19,000 adult patients across 51 studies, discussing evidence indicating a potential relationship between COVID-19 and persistent neurological problems. These problems could range from milder symptoms, including headaches, loss of sense of smell and taste, and fatigue, to more severe conditions, including sleep disorders, pain, and cognitive impairment such as brain fog leading to memory loss or difficulty concentrating or making decisions.

The study found that brain fog affects 20% of Coronavirus long-haulers, while 27% of them reported insomnia, and 24% reported fatigue, both of which researchers believe could stem from neurological issues, although that might not be the only possible cause. Brain fog can have varying impacts on patients; for some, it may be life-altering, while for others can be a minor inconvenience.

However, diagnosing long-term COVID-19 symptoms remains a challenge as doctors are still learning the underlying mechanisms of how the virus works. For example, without knowing how long these neurological symptoms last, doctors are not able to classify them as neurological disorders or even chronic illnesses. The researchers conclude that doctors will need to track long-haulers to decipher whether they have neurological disorders after they suffered and survived Coronavirus infection.

As a growing body of research indicates, the long-term outlook for COVID-19 patients is still uncertain. Long haul Covid-19 survivors will need ongoing medical help to track and manage the long-term impact of the virus on their health, including brain health. That’s where Brain Scientific’s unique technology can help.

The Company has developed NeuroEEG(TM), a portable, wireless device that can record and display the patient’s electrical brain activity that works together with the NeuroCap(TM) — a hospital-grade disposable EEG headset that comes in sizes for adults and pediatric patients.  Brain Scientific is working on developing another revolutionary technology — Brain E-Tattoo(TM), a minimally invasive four-channel implant or imprint tattoo designed for long-term brain wave activity monitoring even beyond the clinical setting. It can provide access to long-term neurological studies, potentially helping identify root neurological problems.

More than a year into the pandemic, it remains a challenge to understand the immediate effect of the virus on brain health, with no definite answer regarding the long-term impact either (https://ibn.fm/xNJLl). The scientific world is only starting to truly grasp the effect of COVID-19 on the brain. Brain Scientific appears poised to be a key player providing unparalleled technology that will potentially contribute to providing answers to the most pressing issues in the modern brain diagnostics space.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, June 10th, 2021 Uncategorized Comments Off on $BRSF Poised to Offer Brain Monitoring Solution as Research Shows Neurological Findings in COVID-19 Long-Haulers

$XPHYF Study Finds Americans Are Receptive to Psychedelic Treatments

The coronavirus pandemic has not only affected the economies of different countries as well as industries around the world, but it has also affected the mental and emotional health of millions of individuals globally.

Field Trip Health, one of the biggest providers of psychedelic therapies globally, recently conducted a survey in the United States focused on both emotional and mental health. The company’s aim was to find out how open-minded respondents were towards including psychedelics into their treatment plans. The survey’s results report that more than 8 out of every 10 individuals who responded experienced at least one symptom of depression. This differs from results of more than 75% of the respondents, who stated that their mental health was OK or better, showing a disparity between self-perception and a potential lack of understanding of mental health metrics.

The survey highlights that only 10% of individuals aged 65 and above self-reported symptoms of depression, which is a small number in comparison with the majority group, which was made up of individuals aged 18 to 24 and had the highest results. In addition to this, one in every four respondents reported that they had thought of harming themselves or had felt that they would be better off dead.

The survey also found that a majority of the participants had turned to coping mechanisms such as drugs to help them deal with negative emotions and thoughts. Other coping mechanisms mentioned included gambling, overeating, porn and alcohol. Reports show that the consumption of alcohol increased by more than 30% since the onset of the pandemic. Despite this, however, more than 40% of the survey participants also relied on the support of a counselor, therapist or mental health professional.

The findings also show that, in comparison with men, women reported worse negative mental health outcomes throughout the pandemic and were more likely to show negative mental health states. This was in addition to bearing the brunt of the negative effects on their financial and professional security. The study results also noted that while 70% of respondents had never used psychedelic substances, more than 30% revealed that they supported the use of these substances in psychedelic-assisted therapies, with more than 20% revealing that they’d like to learn more about psychedelics. Furthermore, 24% of respondents were open to trying psychedelic-assisted therapies.

Currently, more states across the country are moving to legalize the use of these substances in treating various mental conditions. The survey results propose that many may seek these alternative treatment options once they become available.

As public awareness about the medicinal value of psychedelics grows, sector players such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are likely to ramp up their R&D efforts in order to meet the demand when these treatments are finally approved and made available to the general public.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Wednesday, June 9th, 2021 Uncategorized Comments Off on $XPHYF Study Finds Americans Are Receptive to Psychedelic Treatments

$VVOS CEO Discusses Unique System That Rebuilds Human Airway on Relentless Dentist Podcast

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), was featured in a recent episode of the Relentless Dentist podcast. The program features interviews with thought-provoking guests offering words of wisdom to help dentists gain the courage to develop the practices and lives of their dreams. Vivos Therapeutics CEO R. Kirk Huntsman joined the broadcast, hosted by certified High Performance Coach Dr. David Maloley, to discuss his professional background, his introduction to the company’s game-changing Vivos System(R), and his efforts to commercialize the platform for the treatment of sleep-disordered breathing. “Vivos has spent the last four years, literally since late 2016, building infrastructure, and the model is working,” Huntsman said. “Our Vivos-trained independent dentists have treated close to 17,000 patients with [the Vivos System]. … Mandibular advancement was never intended to be a lifelong solution to this problem. It was intended to be palliative and temporary, but neither the medical profession nor the dental profession has any good solution for sleep apnea. … With mandibular advancement and CPAP, the underlying condition gets worse over time. … That’s not true with Vivos. What the Vivos System does that’s unique is we actually rebuild the human airway. The treatment protocol repositions the jaws forward, making the dental arches wider, and they’re doing that in a stable manner.”

To view the full press release, visit https://ibn.fm/Cg9jH

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (“OSA”). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have proven effective in over 17,000 patients treated worldwide by more than 1,200 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, June 9th, 2021 Uncategorized Comments Off on $VVOS CEO Discusses Unique System That Rebuilds Human Airway on Relentless Dentist Podcast